Technosphere insulin has consistently shown signs that it not only improves upon its struggling predecessor ( Pfizer PFE and Nektar's NKTR Exubera), but also that it has the potential to provide better control of glucose levels than the most advanced forms of injectable
(Reuters) - Nektar Therapeutics said its experimental drug to treat chronic pain in patients with arthritis of the knee failed to meet its main goal in a mid-stage clinical trial.
We are dropping coverage of Nektar Therapeutics NKTR to focus our resources elsewhere.
Nektar Therapeutics NKTR reported another quarter of year-over-year revenue decline because of the marketing failure of its inhaled insulin product
estimate in place after reviewing Nektar Therapeutics ' NKTR fourth-quarter results. Total ..... results from a Phase II study of NKTR -118 in patients with opioid ..... Management has indicated that NKTR -118 will be partnered with another
Nektar Therapeutics NKTR announced today that Novartis NVS will ..... programs, including Amikacin Inhale ( NKTR -061), Ciprofloxacin inhaled powder, and inhaled vancomycin ( NKTR -063). While Nektar wasn't in dire
After reviewing Nektar's NKTR second-quarter earnings, we are maintaining our fair value estimate. Second-quarter revenue dropped to $40 million from
Nektar Therapeutics NKTR has been making strides to move past its Exubera failure, and ..... approval, and two of Nektar's proprietary drug candidates-- NKTR -118 and NKTR -102--have recently produced strong results in Phase I studies
Nektar Therapeutics NKTR announced Wednesday that an increased risk of lung cancer was associated with its inhaled insulin when compared with the control
failure of inhaled insulin Exubera, Nektar NKTR is entering 2008 with a growing pipeline ..... partnership with Nektar late last summer for NKTR -061, an inhaled antibiotic that the ..... Nektar's unpartnered pegylation programs, NKTR -102 and NKTR -118, recently advanced